Atlas Trials

Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition

Clinical trial NCT07332338 · AVAILABLE

Trial details

NCT number
NCT07332338
Sponsor
StemCyte, Inc.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Post-COVID-19 ConditionPost-COVID ConditionPost-COVID SyndromeLong COVIDChronic FatigueChronic Fatigue SymptomsFatigue Post Viral

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.